UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2015
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____
| Commission File Number 0-11102 |
| OCEAN BIO-CHEM, INC. |
(Exact name of registrant as specified in its charter)
| Florida | 59-1564329 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
4041 SW 47 AVENUE
FORT LAUDERDALE, FLORIDA 33314
(Address of principal executive offices)
954-587-6280
| (Registrant’s telephone number, including area code) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and smaller reporting company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ | Accelerated filer ☐ | |
| Non-accelerated filer ☐ | Smaller reporting company ☒ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
At May 14, 2015, 8,922,118 shares of the registrant’s Common Stock were outstanding.
OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
TABLE OF CONTENTS
| Page | ||||||
| PART I | Financial Information: | |||||
| Item 1. Financial Statements | 3 | |||||
| Condensed consolidated balance sheets at March 31, 2015 (unaudited) and December 31, 2014 | 3 | |||||
| Condensed consolidated statements of operations (unaudited) for the three months ended March 31, 2015 and 2014 | 4 | |||||
| Condensed consolidated statements of comprehensive income (unaudited) for the three months ended March 31, 2015 and 2014 | 5 | |||||
| Condensed consolidated statements of cash flows (unaudited) for the three months ended March 31, 2015 and 2014 | 6 | |||||
| Notes to condensed consolidated financial statements | 7-12 | |||||
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 13-16 | |||||
| Item 3. Quantitative and Qualitative Disclosures about Market Risk | 17 | |||||
| Item 4. Controls and Procedures | 17 | |||||
| PART II | Other Information: | |||||
| Item 1A. Risk Factors | 17 | |||||
| Item 6. Exhibits | 18 | |||||
| Signatures | 19 | |||||
| 2 |
PART 1-FINANCIAL INFORMATION
| Item 1. | Financial Statements |
OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31, 2015 | December 31, 2014 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current Assets: | ||||||||
| Cash | $ | 2,011,559 | $ | 3,062,729 | ||||
| Trade accounts receivable less allowances of approximately $69,000 and $76,000, respectively | 3,482,159 | 4,850,282 | ||||||
| Receivables due from affiliated companies | 1,047,742 | 715,034 | ||||||
| Inventories, net | 10,097,107 | 8,109,333 | ||||||
| Prepaid expenses and other current assets | 1,065,321 | 844,783 | ||||||
| Deferred tax asset | 125,957 | 123,360 | ||||||
| Total Current Assets | 17,829,845 | 17,705,521 | ||||||
| Property, plant and equipment, net | 5,271,944 | 5,172,882 | ||||||
| Other Assets: | ||||||||
| Intangible assets, net | 1,078,110 | 1,095,458 | ||||||
| Other assets | 5,175 | 6,550 | ||||||
| Total Other Assets | 1,083,285 | 1,102,008 | ||||||
| Total Assets | $ | 24,185,074 | $ | 23,980,411 | ||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable – trade | $ | 1,995,712 | $ | 1,439,868 | ||||
| Current portion of long term debt | 427,036 | 425,658 | ||||||
| Income taxes payable | --- | 16,465 | ||||||
| Accrued expenses payable | 916,597 | 1,115,514 | ||||||
| Total Current Liabilities | 3,339,345 | 2,997,505 | ||||||
| Deferred tax liability | 252,267 | 258,682 | ||||||
| Long term debt, less current portion | 585,383 | 692,104 | ||||||
| Total Liabilities | 4,176,995 | 3,948,291 | ||||||
| Commitments and contingencies | ||||||||
| Shareholders' Equity: | ||||||||
| Common stock - $.01 par value, 12,000,000 shares authorized; 8,922,118 and 8,914,274 shares issued | 89,221 | 89,142 | ||||||
| Additional paid in capital | 9,131,873 | 9,131,952 | ||||||
| Foreign currency translation adjustment | (287,278 | ) | (279,163 | ) | ||||
| Retained earnings | 11,074,263 | 11,090,189 | ||||||
| Total Shareholders' Equity | 20,008,079 | 20,032,120 | ||||||
| Total Liabilities and Shareholders' Equity | $ | 24,185,074 | $ | 23,980,411 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 3 |
OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2015 | 2014 | |||||||
| Gross sales | $ | 6,328,343 | $ | 6,240,025 | ||||
| Less: discounts, returns, and allowances | 325,914 | 319,326 | ||||||
| Net sales | 6,002,429 | 5,920,699 | ||||||
| Cost of goods sold | 3,965,780 | 3,833,036 | ||||||
| Gross profit | 2,036,649 | 2,087,663 | ||||||
| Operating Expenses: | ||||||||
| Advertising and promotion | 615,872 | 583,869 | ||||||
| Selling and administrative | 1,421,546 | 1,152,025 | ||||||
| Total operating expenses | 2,037,418 | 1,735,894 | ||||||
| Operating (loss) income | (769 | ) | 351,769 | |||||
Other (expense) | ||||||||
| Interest, net (expense) | (10,075 | ) | (11,382 | ) | ||||
| Other (expense) | (12,522 | ) | --- | |||||
| (Loss) income before income taxes | (23,366 | ) | 340,387 | |||||
| Benefit (provision) for income taxes | 7,440 | (123,220 | ) | |||||
| Net (loss) income | (15,926 | ) | 217,167 | |||||
| Loss attributable to noncontrolling interests | --- | 6,431 | ||||||
| Net (loss) income attributable to Ocean Bio-Chem, Inc. | $ | (15,926 | ) | $ | 223,598 | |||
| Earnings per common share – basic and diluted | $ | --- | $ | 0.03 | ||||
| Dividends per common share | $ | --- | $ | 0.05 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
| 4 |
OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2015 | 2014 | |||||||
| Net (loss) income | $ | (15,926 | ) | $ | 217,167 | |||
| Foreign currency translation adjustment | (8,115 | ) | (4,161 | ) | ||||
| Comprehensive (loss) income | (24,041 | ) | 213,006 | |||||
| Comprehensive loss attributable to noncontrolling interests | --- | 6,431 | ||||||
| Comprehensive (loss) income attributable to Ocean Bio-Chem, Inc. | $ | (24,041 | ) | $ | 219,437 | |||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
| 5 |
OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2015 | 2014 | |||||||
| Cash flows from operating activities: | ||||||||
| Net (loss) income | $ | (15,926 | ) | $ | 217,167 | |||
| Adjustments to reconcile net income to net cash used in operating activities | ||||||||
| Depreciation and amortization | 221,559 | 201,005 | ||||||
| Deferred income taxes | (9,012 | ) | (2,131 | ) | ||||
| Loss on sale of property, plant and equipment | 12,522 | --- | ||||||
| Other operating non-cash items | 23,874 | (36,886 | ) | |||||
| Changes in assets and liabilities: | ||||||||
| Trade accounts receivable | 1,374,194 | 1,493,516 | ||||||
| Inventories | (2,001,274 | ) | (1,395,797 | ) | ||||
| Other assets | 1,375 | 1,241 | ||||||
| Prepaid expenses and other current assets | (220,538 | ) | (152,556 | ) | ||||
| Receivables due from affiliated companies | (332,708 | ) | (492,619 | ) | ||||
| Accounts payable and other accrued expenses | 340,462 | 164,541 | ||||||
| Net cash used in operating activities | (605,472 | ) | (2,519 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Purchases of property, plant and equipment | (370,795 | ) | (183,490 | ) | ||||
| Proceeds from sale of property, plant, and equipment | 55,000 | --- | ||||||
| Net cash used in investing activities | (315,795 | ) | (183,490 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Payments on long-term debt | (105,343 | ) | (103,627 | ) | ||||
| Proceeds from exercise of stock options | --- | 63,250 | ||||||
| Net cash used in financing activities | (105,343 | ) | (40,377 | ) | ||||
| Effect of exchange rates on cash | (24,560 | ) | (15,271 | ) | ||||
| Net decrease in cash | (1,051,170 | ) | (241,657 | ) | ||||
| Cash at beginning of period | 3,062,729 | 3,071,887 | ||||||
| Cash at end of period | $ | 2,011,559 | $ | 2,830,230 | ||||
| Supplemental disclosure of cash flow information: | ||||||||
| Cash paid for interest during period | $ | 10,379 | $ | 13,974 | ||||
| Cash paid for income taxes during period | $ | 87,000 | $ | 130,000 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 6 |
OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
| 1. | SUMMARY OF ACCOUNTING POLICIES |
Interim reporting
The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its wholly-owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. Certain prior-period data have been reclassified to conform to the current period presentation. Unless the context indicates otherwise, the term “Company” refers to Ocean Bio-Chem, Inc. and its subsidiaries.
The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results to be expected for the year ending December 31, 2015.
The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.
Prior to September 16, 2014, one of the Company’s subsidiaries, OdorStar Technology, LLC (“OdorStar”), was a joint venture in which the Company had a controlling interest and, therefore, OdorStar was included in the Company’s condensed consolidated financial statements for the three months ended March 31, 2014. On September 16, 2014, the Company acquired the joint venture partner’s interest in OdorStar, which became a wholly–owned subsidiary of the Company.
Use of estimates
The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions.
| 2. | RECENT ACCOUNTING PRONOUNCEMENTS |
There have been no accounting pronouncements or changes in accounting pronouncements during the three months ended March 31, 2015 that are expected to have a material impact on the Company’s financial position, results of operations or cash flows. Accounting pronouncements that became effective during the three months ended March 31, 2015 did not have a material impact on disclosures or on the Company’s financial position, results of operations or cash flows.
| 7 |
| 3. | INVENTORIES |
The composition of inventories at March 31, 2015 and December 31, 2014 are as follows:
| March 31, 2015 | December 31, 2014 | |||||||
| Raw materials | $ | 4,089,753 | $ | 3,365,093 | ||||
| Finished goods | 6,298,150 | 5,021,536 | ||||||
| Inventories, gross | 10,387,903 | 8,386,629 | ||||||
| Inventory reserves | (290,796 | ) | (277,296 | ) | ||||
| Inventories, net | $ | 10,097,107 | $ | 8,109,333 | ||||
The inventory reserves shown in the table above reflect slow moving and obsolete inventory.
The Company manages an inventory program for one of its customers to improve the promotion of the Company's products. The Company manages the inventory levels at the customer’s warehouses and recognizes revenue as the products are sold by the customer. The inventories managed at the customer’s warehouses amounted to approximately $474,000 and $493,000 at March 31, 2015 and December 31, 2014, respectively, and are included in inventories, net on the balance sheet.
| 4. | PROPERTY, PLANT & EQUIPMENT |
The Company’s property, plant and equipment consisted of the following at March 31, 2015 and December 31, 2014:
| Estimate Useful Life | March 31, 2015 | December 31, 2014 | ||||||||
| Land | $ | 278,325 | $ | 278,325 | ||||||
| Building and improvements | 30 years | 4,650,349 | 4,648,089 | |||||||
| Manufacturing and warehouse equipment | 6-20 years | 8,635,428 | 8,486,397 | |||||||
| Office equipment and furniture | 3-5 years | 1,094,797 | 1,044,605 | |||||||
| Construction in process | 128,488 | 64,038 | ||||||||
| Leasehold improvements | 10-15 years | 541,521 | 436,659 | |||||||
| Vehicles | 3 years | 42,283 | 131,828 | |||||||
| Property, plant and equipment, gross | 15,371,191 | 15,089,941 | ||||||||
| Less accumulated depreciation | (10,099,247 | ) | (9,917,059 | ) | ||||||
| Property, plant and equipment, net | $ | 5,271,944 | $ | 5,172,882 | ||||||
| 8 |
| 5. | REVOLVING LINE OF CREDIT |
On August 4, 2014, the Company and Regions Bank entered into a Business Loan Agreement (the“Business Loan Agreement”), under which the Company was provided a renewed revolving line of credit. Under the renewed revolving line of credit, the Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable (as defined in the Business Loan Agreement) plus 50% of eligible inventory (as defined in the Business Loan Agreement).Interest on amounts borrowed under the revolving line of credit is payable monthly at the 30 day LIBOR rate plus 1.65% per annum (unless the Company’s debt service coverage ratio (generally, net operating profit plus depreciation, amortization and lease/rent expense divided by current maturities of long-term debt plus interest and lease/rent expense, calculated on a trailing twelve month basis) falls to or below 2.0 to 1, in which case interest is payable at the 30 day LIBOR rate plus 2.65% per annum).
Outstanding amounts under the revolving line of credit are payable on demand. If no demand is made, the Company may repay and reborrow funds from time to time until expiration of the revolving line of credit on July 6, 2016, at which time all outstanding principal and interest will be due and payable. The Company’s obligations under the revolving line of credit are secured by, among other things, the Company’s accounts receivable, inventory, contract rights and general intangibles and, as a result of cross-collateralization of the Company’s obligations under the term loan described in Note 6 and the revolving line of credit, real property and equipment at the Montgomery, Alabama facility of the Company’s subsidiary, Kinpak, Inc. ("Kinpak"). The Business Loan Agreement includes financial covenants requiring a minimum debt service coverage ratio of 1.75 to 1.00, calculated on a trailing twelve month basis, and a maximum debt to capitalization ratio (generally, funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly. At March 31, 2015 and December 31, 2014, the Company was in compliance with these covenants. The line of credit is subject to several events of default, including a decline in the majority shareholder’s ownership below 50% of all outstanding shares. At March 31, 2015 and December 31, 2014, the Company had no borrowings under the revolving line of credit.
| 6. | LONG TERM DEBT |
On July 6, 2011, under the Equipment Finance Addendum to the Credit Agreement, REFCO provided to the Company a $2,430,000 term loan with a fixed interest rate of 3.54%, subject to an increase to 4.55% in the event the Company's debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense, calculated on a trailing four-quarter basis) falls to or below 2.0 to 1. Principal and interest on the term loan are payable in equal monthly installments through July 6, 2017, the date on which the term loan matures. The proceeds of the term loan were used to pay the Company’s remaining obligations under a lease agreement relating to industrial revenue bonds used to fund the expansion of Kinpak’s facilities and acquisition of related equipment. At March 31, 2015, approximately $1,007,000 was outstanding under the term loan. The term loan and the revolving line of credit under the Bank Loan Agreement are cross-defaulted (i.e., a default under one instrument is a default under the other).
At March 31, 2015 and December 31, 2014, the Company was obligated under various capital lease agreements covering equipment utilized in the Company’s operations. The capital leases, aggregating $5,753 and $8,081 at March 31, 2015 and December 31, 2014, respectively, have varying maturities through 2015 and carry an interest rate of 14%.
The following table provides information regarding the Company’s long term debt at March 31, 2015 and December 31, 2014:
| Current Portion | Long Term Portion | |||||||||||||||
| March 31, 2015 | December 31, 2014 | March 31, 2015 | December 31, 2014 | |||||||||||||
| Term loan | $ | 421,283 | $ | 417,577 | $ | 585,383 | $ | 692,104 | ||||||||
| Capitalized equipment leases | 5,753 | 8,081 | --- | --- | ||||||||||||
| Total long term debt | $ | 427,036 | $ | 425,658 | $ | 585,383 | $ | 692,104 | ||||||||
Required principal payments under the Company’s long term obligations are set forth below:
| 12 month period ending March 31, | ||||||
| 2016 | $ | 427,036 | ||||
| 2017 | 436,441 | |||||
| 2018 | 148,942 | |||||
| Total | $ | 1,012,419 | ||||
| 9 |
| 7. | RELATED PARTY TRANSACTIONS |
During the three months ended March 31, 2015 and 2014, the Company sold products to companies affiliated with its Chairman, President and Chief Executive Officer. The affiliated companies distribute the products outside of the United States and Canada. The Company also provides administrative services to these companies. Sales to the affiliated companies aggregated approximately $725,000 and $713,000 during the three months ended March 31, 2015 and 2014, respectively. Administrative fees aggregated approximately $107,000 and $92,000 during the three months ended March 31, 2015 and 2014, respectively. The Company had accounts receivable from the affiliated companies in connection with the product sales and administrative services aggregating approximately $1,048,000 and $715,000 at March 31, 2015 and December 31, 2014, respectively. Transactions with the affiliated companies were made in the ordinary course of business. While the terms of sale to the affiliated companies differed from the terms applicable to other customers, the affiliated companies bear their own warehousing, distribution, advertising, selling and marketing costs, as well as their own freight charges (the Company pays freight charges in connection with sales to its domestic customers on all but small orders). Moreover, the Company does not pay sales commissions with respect to products sold to the affiliated companies. As a result, the Company believes its profit margins with respect to sales to the affiliated companies are similar to the profit margins with respect to sales to its larger domestic customers. Management believes that the sales transactions did not involve more than normal credit risk or present other unfavorable features.
A subsidiary of the Company currently uses the services of an entity that is owned by its Chairman, President and Chief Executive Officer to conduct product research and development and to assist in the production of television commercials. Under this arrangement, the Company paid the entity $10,500 for each of the three month periods ended March 31, 2015 and 2014, for research and development services. In addition, during the year ended December 31, 2014, the Company made a $40,000 prepayment to this entity for the production of television commercials. The Company’s condensed consolidated balance sheets include the $40,000 prepayment in prepaid expenses and other current assets at March 31, 2015 and December 31, 2014, respectively.
The Company leases office and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer. The Company believes that the rental payments are below market rates. See Note 8 for a description of the lease terms.
A director of the Company is Regional Executive Vice President of an entity from which the Company sources most of its insurance needs at an arm’s length competitive basis. During the three months ended March 31, 2015 and 2014, the Company paid an aggregate of approximately $216,000 and $217,000, respectively, in insurance premiums on policies obtained through the entity.
| 8. | COMMITMENTS AND CONTINGENCIES |
The Company leases its executive offices and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer. The lease, as extended, expires on December 31, 2023. The lease requires an annual minimum base rent of $94,800 and provides for a maximum annual 2% increase in subsequent years, although the entity has not raised the minimum rent since the Company entered into a previous lease agreement in 1998. Additionally, the leasing entity is entitled to reimbursement of all taxes, assessments, and any other expenses that arise from ownership. Each of the parties to the lease has agreed to review the terms of the lease every three years at the request of the other party. Rent expense under the lease was approximately $24,000 for each of the three months ended March 31, 2015 and 2014, respectively.
On November 25, 2013, OdorStar and Kinpak filed a Second Amended Complaint in the United States District Court for the Southern District of Florida, which amended a complaint initially filed on January 18, 2013, alleges that Biocide manufactured, used, sold and continues to sell an odor-eliminating product that infringes OdorStar's U.S. Patent No. 6,764,661 (“the ‘661 patent”), relating to a device for producing chlorine dioxide. Biocide denied infringement and both sides moved for summary judgment. On January 27, 2014, the District Court granted the defendants' motion for summary judgment of non-infringement and denied the plaintiffs' motion. On January 8, 2015 the Court of Appeal affirmed the District Court’s judgement. On March 27, 2014, SSM Distributors LLC, d/b/a Biocide Systems, and SSM Manufacturing, Inc. (SMM Distributors LLC is now defunct) filed a motion with the District Court seeking payment by OdorStar and Kinpak of their attorneys’ fees and non-taxable costs in the amount of $259,550, based on, among other things, the defendants’ contention that the plaintiffs' patent infringement claims were vexatious and intended to intimidate the defendants into withdrawing from competition with the plaintiffs. OdorStar and Kinpak filed an opposition to the motion, essentially denying the defendants' contentions and stating that defendants were not entitled to payment of their attorneys’ fees under applicable legal standards. On March 2, 2015, the District Court denied the defendants’ motion.
| 10 |
| 9. | EARNINGS PER SHARE |
Basic earnings per share is calculated based on net income attributable to Ocean Bio-Chem, Inc. and the weighted average number of shares outstanding during the reported period. Diluted earnings per share reflect additional dilution from potential common stock issuable upon the exercise of outstanding stock options using the treasury stock method. The following table sets forth the computation of basic and diluted earnings per common share, as well as a reconciliation of the weighted average number of common shares outstanding to the weighted average number of shares outstanding on a diluted basis.
| Three Months Ended March 31, | ||||||||
| 2015 | 2014 | |||||||
| Earnings per common share -Basic | ||||||||
| Net (loss) income attributable to OBCI | $ | (15,926 | ) | $ | 223,598 | |||
| Weighted average number of common shares outstanding | 8,920,288 | 8,690,074 | ||||||
| Earnings per common share - Basic | $ | 0.00 | $ | 0.03 | ||||
| Earnings per common share – Diluted | ||||||||
| Net (loss) income attributable to OBCI | $ | (15,926 | ) | $ | 223,598 | |||
| Weighted average number of common shares outstanding | 8,920,288 | 8,690,074 | ||||||
| Dilutive effect of employee stock-based awards | --- | 173,050 | ||||||
| Weighted average number of common shares outstanding - assuming dilution | 8,920,288 | 8,863,124 | ||||||
| Earnings per common share - Diluted | $ | 0.00 | $ | 0.03 | ||||
For the three months ended March 31, 2015 and March 31, 2014, 99,689 and 0 shares underlying outstanding stock awards were not included in the computation of earnings per common share – diluted because their effect was antidilutive.
| 11 |
| 10. | SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS |
During the three months ended March 31, 2015, stock options to purchase an aggregate of 10,000 shares were exercised. Following the withholding of an aggregate of 2,156 shares in connection with the net exercise feature of the stock options, the Company delivered an aggregate of 7,844 shares to the option holder who exercised his options.
There was no stock compensation expense attributable to stock options during the three months ended March 31, 2015 and 2014. At March 31, 2015, there was no unrecognized compensation expense related to stock options.
There were no stock awards issued during the three months ended March 31, 2015 and 2014.
The following table provides information at March 31, 2015 regarding outstanding stock options under the Company’s stock option plans. As used in the table below, “2002 NQ” refers to the Company’s 2002 Non-Qualified Stock Option Plan and “2008 NQ” refers to the Company’s 2008 Non-Qualified Stock Option Plan.
| Plan | Date Granted | Options Outstanding | Exercisable Options | Exercise Price | Expiration Date | Weighted Average Remaining Life | ||||||||||||||
| 2002NQ | 4/03/06 | 30,000 | 30,000 | $ | 1.08 | 4/02/16 | 1.0 | |||||||||||||
| 2002NQ | 12/17/07 | 40,000 | 40,000 | $ | 1.32 | 12/16/17 | 2.8 | |||||||||||||
| 2008NQ | 1/11/09 | 40,000 | 40,000 | $ | 0.69 | 1/10/19 | 3.8 | |||||||||||||
| 2008NQ | 4/26/10 | 20,000 | 20,000 | $ | 2.07 | 4/25/20 | 5.1 | |||||||||||||
| 130,000 | 130,000 | $ | 1.19 | 3.1 | ||||||||||||||||
| 12 |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Forward-looking Statements:
Certain statements contained in this Quarterly Report on Form 10-Q, including without limitation, our ability to provide required capital to support inventory levels, the effect of price increases in raw materials that are petroleum or chemical based or commodity chemicals on our margins, and the sufficiency of funds provided through operations and existing sources of financing to satisfy our cash requirements constitute forward-looking statements. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed forward-looking statements. Without limiting the generality of the foregoing, words such as "believe," "may," "will," "expect," "anticipate," "intend," or "could," including the negative or other variations thereof or comparable terminology, are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors which may cause actual results to be materially different from those expressed or implied by such forward-looking statements. Factors that may affect these results include, but are not limited to, the highly competitive nature of our industry; reliance on certain key customers; changes in consumer demand for marine, recreational vehicle and automotive products; advertising and promotional efforts; exposure to market risks relating to changes in interest rates, foreign exchange rates, prices for raw materials that are petroleum or chemical based and other factors.
Overview:
We are principally engaged in manufacturing, marketing and distributing a broad line of appearance, performance and maintenance products for the marine, automotive, power sports, recreational vehicle and outdoor power equipment markets, under the Star brite®, StarTron® and other trademarks within the United States of America and Canada. In addition, we produce private label formulations of many of our products for various customers and provide custom blending and packaging services for these and other products. We also manufacture, market and distribute a line of disinfectant, sanitizing and deodorizing products. We sell our products to national retailers and to national and regional distributors who sell our products to specialized retail outlets.
Critical accounting estimates:
See “Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates" in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2014 for information regarding our critical accounting estimates.
Results of Operations:
Three Months Ended March 31, 2015 Compared to the Three Months Ended March 31, 2014
The following table provides a summary of our financial results for the three months ended March 31, 2015 and 2014:
| For The Three Months Ended March 31, | ||||||||||||||||||||
| Percent | Percentage of Net sales | |||||||||||||||||||
| 2015 | 2014 | Change | 2015 | 2014 | ||||||||||||||||
| Net sales | $ | 6,002,429 | $ | 5,920,699 | 1.4 | % | 100.0 | % | 100.0 | % | ||||||||||
| Cost of Goods sold | 3,965,780 | 3,833,036 | 3.5 | % | 66.1 | % | 64.7 | % | ||||||||||||
| Gross Profit | 2,036,649 | 2,087,663 | (2.4 | )% | 33.9 | % | 35.3 | % | ||||||||||||
| Advertising and promotion | 615,872 | 583,869 | 5.5 | % | 10.3 | % | 9.9 | % | ||||||||||||
| Selling and administrative | 1,421,546 | 1,152,025 | 23.4 | % | 23.7 | % | 19.5 | % | ||||||||||||
| Operating (loss) income | (769 | ) | 351,769 | (100.2 | )% | 0.0 | % | 5.9 | % | |||||||||||
| Interest (expense), net | (10,075 | ) | (11,382 | ) | (11.5 | )% | 0.2 | % | 0.2 | % | ||||||||||
| Other (expense) | (12,522 | ) | --- | N/A | 0.2 | % | 0.0 | % | ||||||||||||
| Benefit (Provision) for income taxes | 7,440 | (123,220 | ) | 106.0 | % | (0.1 | )% | 2.1 | % | |||||||||||
| Net (loss) income | $ | (15,926 | ) | $ | 217,167 | (107.3 | )% | (0.3 | )% | 3.7 | % | |||||||||
| Net (loss) income attributable to OBCI | $ | (15,926 | ) | $ | 223,598 | (107.1 | )% | (0.3 | )% | 3.8 | % | |||||||||
| 13 |
Net sales increased by $81,000 or 1.4% to approximately $6,002,000 for the three months ended March 31, 2015 from approximately $5,921,000 during the same period in 2014. Despite the increase, and as was the case in the 2014 period, net sales, principally with respect to our marine products, were adversely affected by unusually cold weather in many portions of the United States.
Cost of goods sold increased by approximately $133,000 or 3.5% to approximately $3,966,000 during the three months ended March 31, 2015, from approximately $3,833,000 during the same period in 2014. The increase in cost of goods sold reflects a less favorable product mix and the increase in net sales.
Gross profit decreased by approximately $51,000 or 2.4% to approximately $2,037,000 for the three months ended March 31, 2015, from approximately $2,088,000 during the same period in 2014, as the result of the factors described above. As a percentage of net sales, gross profit was approximately 33.9% and 35.3% for the three month periods ended March 31, 2015 and 2014 respectively.
Advertising and promotion expenses increased by $32,000 or 5.5% to approximately $616,000 for the three months ended March 31, 2015 from approximately $584,000 during the same period in 2014. As a percentage of net sales, advertising and promotion expense was approximately 10.3% in the first quarter of 2015 compared to approximately 9.9% in the first quarter of 2014. The increase is a result of increased internet advertising.
Selling and administrative expenses increased by approximately $270,000 or 23.4%, from approximately $1,152,000 during the three months ended March 31, 2014 to approximately $1,422,000 during the same period in 2015. The increase is a result of increased legal fees, a smaller reduction of our accounts receivable allowance, higher premiums for general liability and employee health insurance, increased sales-related travel & entertainment, and higher salary expense. As a percentage of net sales, selling and administrative expenses increased to 23.7% during the first quarter of 2015 compared to 19.5% in the first quarter of 2014.
Interest expense, net decreased by approximately $1,000 to approximately $10,000 during the three months ended March 31, 2015, compared to approximately $11,000 during the three months ended March 31, 2014. The decrease reflects the declining outstanding principal on our term loan.
Operating (loss) income – As a result of the foregoing, we had an operating loss of approximately $1,000 in the first quarter of 2015 compared to operating income of approximately $352,000 in the same period in 2014.
Income taxes – We had an income tax benefit of approximately $7,000, or 31.8% of our pretax loss in the first quarter of 2015, compared to income tax expense of $123,000 or 36.2% of pretax income, during the first quarter of 2014. The lower tax rate reflects our projected rate for the full year of 2015, which is consistent with the year ended December 31, 2014.
Net (loss) income and Net (loss) income attributable to Ocean Bio-Chem, Inc. - As a result of the factors described above, the Company had a net loss for the first quarter of 2015 of approximately $16,000, compared to net income of $217,000 for the same period in 2014. Net loss attributable to Ocean Bio-Chem. Inc. for the first quarter of 2015 is approximately $16,000, compared to net income attributable to Ocean Bio-Chem. Inc. of approximately $224,000 in the first quarter 2014. Net income attributable to Ocean Bio-Chem, Inc. for the 2014 period does not include a loss of approximately $6,000 that is attributable to the ownership interest of our former joint venture partner in OdorStar Technology, LLC (“OdorStar”).
| 14 |
Liquidity and capital resources:
Our cash balance was approximately $2,012,000 at March 31, 2015 compared to approximately $3,063,000 at December 31, 2014. At March 31, 2015 and December 31, 2014, we had no borrowings under our revolving line of credit.
Net cash used in operating activities during the three months ended March 31, 2015 was approximately $605,000 compared to net cash used in operating activities of approximately $3,000 for the three months ended March 31, 2014. The increase in cash used in operating activities is primarily due to increased inventory purchases, lower net income and a lower net decrease in trade accounts receivable, partially offset by changes in receivables due from affiliated companies and accounts payable and other accrued expenses.
Net trade accounts receivable aggregated approximately $3,482,000 at March 31, 2015 a decrease of approximately $1,368,000 or 28.2% compared to net trade accounts receivable of $4,850,000 at December 31, 2014. The higher trade accounts receivable balance at December 31, 2014 is principally due to higher sales in the fourth quarter of 2014 compared to the first quarter of 2015, reflecting both the success of a company sales initiative to increase fourth quarter 2014 sales and the adverse effect on first quarter 2015 sales of unusually severe weather.
Inventories, net increased by approximately $1,988,000 or 24.5% from approximately $8,109,000 at December 31, 2014 to approximately $10,097,000 at March 31, 2015. We have increased our inventory in anticipation of the second quarter sales.
Net cash used in investing activities was approximately $316,000 for the three months ended March 31, 2015 compared to approximately $183,000 for the three months ended March 31, 2014. The increase in cash used is primarily due to leasehold improvements to expand office space at our corporate headquarters, partially offset by the sale of a recreational vehicle we purchased in 2014 for advertising and exhibiting our products at trade shows and other events.
Net cash used in financing activities was approximately $105,000 for the three months ended March 31, 2015 compared to net cash used of approximately $40,000 during the three months ended March 31, 2014. While both periods reflect repayments under our term loan, cash used in the 2014 period was considerably offset by $63,000 in cash proceeds resulting from the exercise of stock options in the first quarter of 2014.
During the quarter ended March 31, 2014, the Company's Board of Directors declared a special cash dividend of $0.05 per share, which was paid to shareholders of record on April 1, 2014. The aggregate dividend payment totaled $440,016.
On July 6, 2011, we, together with our subsidiary, Kinpak Inc. (“Kinpak”), entered into a Credit Agreement with Regions Bank (and, pursuant to an Equipment Finance Addendum to the Credit Agreement, Regions Equipment Finance Corporation (“REFCO”)) under which (a) Regions Bank provided a revolving line of credit to us (which was replaced by the revolving line of credit described below), and (b) REFCO provided a term loan in the amount of $2,430,000, the proceeds of which were used to pay Kinpak’s remaining lease obligations in connection with the previously outstanding 2002 Series of Industrial Development Revenue Bonds issued by the City of Montgomery, Alabama (the “2002 Bonds”). The 2002 Bonds were used to fund the expansion of Kinpak’s facilities and acquisition of related equipment.
Under the term loan, we pay principal, together with interest at the fixed rate of 3.54% per annum, in 72 consecutive monthly payments of $37,511 over the six year period beginning on August 6, 2011, with the final payment due on July 6, 2017. In the event our debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense, calculated on a trailing four quarter basis), falls to or below 2.0 to 1, interest on the term loan will increase to 4.55% per annum. At March 31, 2015, our debt service coverage ratio was approximately 6.4 to 1.
On August 4, 2014, we entered into a new Business Loan Agreement with Regions Bank (the "Business Loan Agreement") under which we were provided a new revolving line of credit. Under the revolving line of credit, we may borrow up to the lesser of (i) $6 million and (ii) a borrowing base equal to 80% of eligible accounts receivable (as defined in the Business Loan Agreement) plus 50% of eligible inventory (as defined in the Business Loan Agreement). Interest on the revolving line of credit is payable monthly at the 30 day LIBOR rate plus 1.65% per annum (unless our debt service coverage ratio (generally, net operating profit plus depreciation, amortization and lease/rent expense divided by current maturities of long-term debt plus interest and lease/rent expense, calculated on a trailing twelve month basis) falls to or below 2.0 to 1, in which case in which case the interest is payable at the 30 day LIBOR rate plus 2.65% per annum). Outstanding amounts under the revolving line of credit are payable on demand. If no demand is made, we may repay and reborrow funds from time to time, until expiration of the revolving line of credit on July 6, 2016, at which time all outstanding principal and interest is due and payable.
The Business Loan Agreement contains various covenants, including financial covenants requiring a minimum debt coverage ratio of 1.75 to 1.00, tested on a rolling four-quarter basis, and a maximum debt to capitalization ratio (generally, funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly. At March 31, 2015, our debt coverage ratio was approximately 6.4 to 1, and our debt to capitalization ratio was approximately .05 to 1.
Our obligations under the Credit Agreement are secured by our accounts receivable and inventory, as well as real property and equipment at Kinpak’s Montgomery, Alabama facility.
| 15 |
In addition to the revolving line of credit and term loan, we have obtained financing through capital leases for office equipment, totaling approximately $6,000 and $8,000 at March 31, 2015 and December 31, 2014, respectively.
At March 31, 2015, we had no borrowings under our revolving line of credit. See Notes 5 and 6 to the condensed consolidated financial statements included in this report for additional information regarding our debt obligations.
Some of our assets and liabilities are in the Canadian dollars and are subject to currency fluctuations relating to the Canadian dollar. We do not engage in currency hedging and address currency risk as a pricing issue. In the three months ended March 31, 2015, we recorded approximately $8,000 in foreign currency translation adjustments (decreasing shareholders’ equity by $8,000).
During the past few years, we have introduced a number of new products. At times, new product introductions have required us to increase our overall inventory and have resulted in lower inventory turnover rates. The effects of reduced inventory turnover have not been material to our overall operations. We believe that all required capital to maintain such increases will continue to be provided by operations and, if necessary, our current revolving line of credit or a renewal or replacement of the facility. However, we cannot assure that we will be able to secure such a renewal or replacement of our revolving line of credit.
Many of the raw materials that we use in the manufacturing process are petroleum or chemical based and commodity chemicals that are subject to fluctuating prices. The nature of our business does not enable us to pass through the price increases to our national retailer customers and to our distributors as promptly as we experience increases in raw material costs. This may, at times, adversely affect our margins.
At March 31, 2015 and through the date of this report, we did not and do not have any material commitments for capital expenditures.
We believe that funds provided through operations and our existing sources of financing will be sufficient to satisfy our cash requirements over at least the next twelve months.
| 16 |
| Item 3. | Quantitative and Qualitative Disclosures about Market Risk |
Not applicable
| Item 4. | Controls and Procedures |
Evaluation of Disclosure Controls and Procedures:
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of the end of the period covered by this report are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act are (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.
Change in Internal Controls over Financial Reporting:
No change in internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II - OTHER INFORMATION
| Item 1A. | Risk Factors |
In addition to the information set forth in this report, you should carefully consider the factors discussed in Part I -Item 1A, "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2014, which could materially affect the Company’s business, financial condition or future results.
| 17 |
| Item 6. | Exhibits |
| Exhibit No. | Description | |
| 31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act. | |
| 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act. | |
| 32.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350. | |
| 32.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350. | |
| 101 | The following materials from Ocean Bio-Chem, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March, 31, 2015, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of March 31, 2015 and December 31, 2014, (ii) Condensed Consolidated Statements of Operations for the three months ended March 31, 2015 and 2014, (iii) Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2015 and 2014; (iv) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2015 and 2014 and (v) Notes to Condensed Consolidated Financial Statements. |
| 18 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the Undersigned thereunto duly authorized.
| OCEAN BIO-CHEM, INC. | |
| Dated: May 15, 2015 | /s/ Peter G. Dornau |
| Peter G. Dornau | |
| Chairman of the Board, President and | |
| Chief Executive Officer | |
| Dated: May 15, 2015 | /s/ Jeffrey S. Barocas |
| Jeffrey S. Barocas | |
| Vice President and | |
| Chief Financial Officer |
19
EXHIBIT 31.1
CERTIFICATION
I, Peter G. Dornau certify that:
1. I have reviewed this quarterly report on Form 10-Q of Ocean Bio-Chem, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Dated: May 15, 2015 | By: | /s/ Peter G. Dornau |
| Peter G. Dornau | ||
| Chairman of the Board, President and | ||
| Chief Executive Officer |
EXHIBIT 31.2
CERTIFICATION
I, Jeffrey S. Barocas certify that:
1. I have reviewed this quarterly report on Form 10-Q of Ocean Bio-Chem, Inc;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Dated: May 15, 2015 | By: | /s/ Jeffrey S. Barocas |
| Jeffrey S. Barocas | ||
| Vice President | ||
| Chief Financial Officer |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO RULE 13a-14(b)
UNDER THE SECURITIES EXCHANGE ACT AND 18 U.S.C. 1350
I, Peter G. Dornau, Chief Executive Officer of Ocean Bio-Chem, Inc. (the "Company"), hereby certify that, based on my knowledge:
| 1. | The Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: May 15, 2015 | By: | /s/ Peter G. Dornau |
| Peter G. Dornau | ||
| Chairman of the Board, President and | ||
Chief Executive Officer |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO RULE 13a-14(b)
UNDER THE SECURITIES EXCHANGE ACT AND 18 U.S.C. 1350
I, Jeffrey S. Barocas, Chief Financial Officer of Ocean Bio-Chem, Inc. (the "Company"), hereby certify that, based on my knowledge:
| 1. | The Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: May 15, 2015 | By: | /s/ Jeffrey S. Barocas |
| Jeffrey S. Barocas | ||
| Vice President | ||
Chief Financial Officer |